These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19297477)

  • 1. Recombinant Mycobacterium bovis BCG prime-recombinant adenovirus boost vaccination in rhesus monkeys elicits robust polyfunctional simian immunodeficiency virus-specific T-cell responses.
    Cayabyab MJ; Korioth-Schmitz B; Sun Y; Carville A; Balachandran H; Miura A; Carlson KR; Buzby AP; Haynes BF; Jacobs WR; Letvin NL
    J Virol; 2009 Jun; 83(11):5505-13. PubMed ID: 19297477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kinetics of specific immune responses in rhesus monkeys inoculated with live recombinant BCG expressing SIV Gag, Pol, Env, and Nef proteins.
    Leung NJ; Aldovini A; Young R; Jarvis MA; Smith JM; Meyer D; Anderson DE; Carlos MP; Gardner MB; Torres JV
    Virology; 2000 Mar; 268(1):94-103. PubMed ID: 10683331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhesus immune responses to SIV Gag expressed by recombinant BCG vectors are independent from pre-existing mycobacterial immunity.
    Korioth-Schmitz B; Perley CC; Sixsmith JD; Click EM; Lee S; Letvin NL; Frothingham R
    Vaccine; 2015 Oct; 33(42):5715-5722. PubMed ID: 26192357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of seven new recombinant yellow fever viruses 17D expressing fragments of SIVmac239 Gag, Nef, and Vif in Indian rhesus macaques.
    Martins MA; Bonaldo MC; Rudersdorf RA; Piaskowski SM; Rakasz EG; Weisgrau KL; Furlott JR; Eernisse CM; Veloso de Santana MG; Hidalgo B; Friedrich TC; Chiuchiolo MJ; Parks CL; Wilson NA; Allison DB; Galler R; Watkins DI
    PLoS One; 2013; 8(1):e54434. PubMed ID: 23336000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prime-boost vaccination using recombinant Mycobacterium bovis BCG and recombinant vaccinia virus DIs harboring HIV-1 CRF01_AE gag in mice: influence of immunization routes.
    Promkhatkaew D; Matsuo K; Pinyosukhee N; Thongdeejaroen W; Leang-Aramgul P; Sawanpanyalert P; Warachit P
    Southeast Asian J Trop Med Public Health; 2009 Mar; 40(2):273-81. PubMed ID: 19323012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust vaccine-elicited cellular immune responses in breast milk following systemic simian immunodeficiency virus DNA prime and live virus vector boost vaccination of lactating rhesus monkeys.
    Wilks AB; Christian EC; Seaman MS; Sircar P; Carville A; Gomez CE; Esteban M; Pantaleo G; Barouch DH; Letvin NL; Permar SR
    J Immunol; 2010 Dec; 185(11):7097-106. PubMed ID: 21041730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 rhesus macaques.
    Malkevitch N; Patterson LJ; Aldrich K; Richardson E; Alvord WG; Robert-Guroff M
    J Immunol; 2003 Apr; 170(8):4281-9. PubMed ID: 12682263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intradermal and oral immunization with recombinant Mycobacterium bovis BCG expressing the simian immunodeficiency virus Gag protein induces long-lasting, antigen-specific immune responses in guinea pigs.
    Kawahara M; Matsuo K; Honda M
    Clin Immunol; 2006 Apr; 119(1):67-78. PubMed ID: 16386958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8 T Cells Show Protection against Highly Pathogenic Simian Immunodeficiency Virus (SIV) after Vaccination with SIV Gene-Expressing BCG Prime and Vaccinia Virus/Sendai Virus Vector Boosts.
    Kato S; Shida H; Okamura T; Zhang X; Miura T; Mukai T; Inoue M; Shu T; Naruse TK; Kimura A; Yasutomi Y; Matsuo K
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33087465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant Mycobacterium bovis bacillus Calmette-Guérin vectors prime for strong cellular responses to simian immunodeficiency virus gag in rhesus macaques.
    Sixsmith JD; Panas MW; Lee S; Gillard GO; White K; Lifton MA; Balachandran H; Mach L; Miller JP; Lavine C; DeMarco CT; Tomaras GD; Gee C; Porcelli SA; Larsen MH; Frothingham R; Schmitz JE; Jacobs WR; Haynes BF; Letvin NL; Korioth-Schmitz B
    Clin Vaccine Immunol; 2014 Oct; 21(10):1385-95. PubMed ID: 25080550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving Mycobacterium bovis bacillus Calmette-Guèrin as a vaccine delivery vector for viral antigens by incorporation of glycolipid activators of NKT cells.
    Venkataswamy MM; Ng TW; Kharkwal SS; Carreño LJ; Johnson AJ; Kunnath-Velayudhan S; Liu Z; Bittman R; Jervis PJ; Cox LR; Besra GS; Wen X; Yuan W; Tsuji M; Li X; Ho DD; Chan J; Lee S; Frothingham R; Haynes BF; Panas MW; Gillard GO; Sixsmith JD; Korioth-Schmitz B; Schmitz JE; Larsen MH; Jacobs WR; Porcelli SA
    PLoS One; 2014; 9(9):e108383. PubMed ID: 25255287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral immunization with recombinant Mycobacterium bovis BCG simian immunodeficiency virus nef induces local and systemic cytotoxic T-lymphocyte responses in mice.
    Lagranderie M; Balazuc AM; Gicquel B; Gheorghiu M
    J Virol; 1997 Mar; 71(3):2303-9. PubMed ID: 9032366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Priming with recombinant auxotrophic BCG expressing HIV-1 Gag, RT and Gp120 and boosting with recombinant MVA induces a robust T cell response in mice.
    Chapman R; Stutz H; Jacobs W; Shephard E; Williamson AL
    PLoS One; 2013; 8(8):e71601. PubMed ID: 23977084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant Mycobacterium bovis BCG vector system expressing SIV Gag protein stably and persistently induces antigen-specific humoral immune response concomitant with IFN gamma response, even at three years after immunization.
    Kawahara M
    Clin Immunol; 2008 Dec; 129(3):492-8. PubMed ID: 18849196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Priming T-cell responses with recombinant measles vaccine vector in a heterologous prime-boost setting in non-human primates.
    Bolton DL; Santra S; Swett-Tapia C; Custers J; Song K; Balachandran H; Mach L; Naim H; Kozlowski PA; Lifton M; Goudsmit J; Letvin N; Roederer M; Radošević K
    Vaccine; 2012 Sep; 30(41):5991-8. PubMed ID: 22732429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal administration of three recombinant Mycobacterium bovis BCG-SIVmac251 strains to cynomolgus macaques induces rectal IgAs and boosts systemic cellular immune responses that are primed by intradermal vaccination.
    Méderlé I; Le Grand R; Vaslin B; Badell E; Vingert B; Dormont D; Gicquel B; Winter N
    Vaccine; 2003 Oct; 21(27-30):4153-66. PubMed ID: 14505895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Priming with a recombinant pantothenate auxotroph of Mycobacterium bovis BCG and boosting with MVA elicits HIV-1 Gag specific CD8+ T cells.
    Chapman R; Shephard E; Stutz H; Douglass N; Sambandamurthy V; Garcia I; Ryffel B; Jacobs W; Williamson AL
    PLoS One; 2012; 7(3):e32769. PubMed ID: 22479338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant Mycobacterium bovis bacillus Calmette-Guerin elicits human immunodeficiency virus type 1 envelope-specific T lymphocytes at mucosal sites.
    Yu JS; Peacock JW; Jacobs WR; Frothingham R; Letvin NL; Liao HX; Haynes BF
    Clin Vaccine Immunol; 2007 Jul; 14(7):886-93. PubMed ID: 17507541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Priming-boosting vaccination with recombinant Mycobacterium bovis bacillus Calmette-Guérin and a nonreplicating vaccinia virus recombinant leads to long-lasting and effective immunity.
    Ami Y; Izumi Y; Matsuo K; Someya K; Kanekiyo M; Horibata S; Yoshino N; Sakai K; Shinohara K; Matsumoto S; Yamada T; Yamazaki S; Yamamoto N; Honda M
    J Virol; 2005 Oct; 79(20):12871-9. PubMed ID: 16188989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with Gag, Vif, and Nef gene fragments affords partial control of viral replication after mucosal challenge with SIVmac239.
    Martins MA; Wilson NA; Piaskowski SM; Weisgrau KL; Furlott JR; Bonaldo MC; Veloso de Santana MG; Rudersdorf RA; Rakasz EG; Keating KD; Chiuchiolo MJ; Piatak M; Allison DB; Parks CL; Galler R; Lifson JD; Watkins DI
    J Virol; 2014 Jul; 88(13):7493-516. PubMed ID: 24741098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.